Clinical application of totally implantable venous access ports in patients with breast cancer

Abstract

Background Totally implantable venous access port (TIVAP) has become an effective approach for venous access chemotherapy in cancer treatment. We aimed to show the important procedures of clinical application of TIVAP and complications management in breast cancer.Patients and Methods From January 2013 to December 2017, patients with breast cancer who took TIVAP operation were investigated. The key procedures of TIVAP conduct and its complications were evaluated in this study.Results One hundred and ten ports were applied to 110 patients with breast cancer. All ports were successfully implanted in all patients including 108 male and 2 male patients. Patients were followed for an average of 275 days. Conclusion It is safe and effective of TIVAP implantation by blind puncture applied in patients with breast cancer. Chemotherapeutic drugs delivery on the placement day seems safe and showed no more complications.

Factors associated with unscheduled venous access port removal in cancer patients

“…IVAP is used more frequently than in the past, mostly in cancer patients for its benefits in preventing repetitive punctures and irritation and safety in long-lasting treatment schedules (13). It is suitable for high-concentration medications, reduces the discomfort caused by frequent venipuncture, prevents damage to peripheral superficial veins, and reduces restrictions in daily activities, ultimately improving quality of life (13). Its maintenance is also easier after wound healing.…”